{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:54:59Z","timestamp":1791017699313,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,3]]},"DOI":"10.7759\/cureus.117379","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:32:09Z","timestamp":1791016329000},"source":"Crossref","is-referenced-by-count":0,"title":["Spontaneous Tumour Lysis Syndrome in Metastatic Endometrial Carcinoma"],"prefix":"10.7759","author":[{"given":"Katherine","family":"Coggins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo MS","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004, 127:3-11. 10.1111\/j.1365-2141.2004.05094.x","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506153322407","article-title":"Childhood leukemias","volume":"332","author":"Pui CH","year":"1995","unstructured":"Pui CH. Childhood leukemias. N Engl J Med. 1995, 332:1618-30. 10.1056\/NEJM199506153322407","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard SC","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011, 364:1844-54. 10.1056\/NEJMra0904569","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2020.100140","article-title":"Pathophysiology of hyperuricemia and its clinical significance - a narrative review","volume":"58","author":"Skoczy\u0144ska M","year":"2020","unstructured":"Skoczy\u0144ska M, Chowaniec M, Szymczak A, Langner-Hetma\u0144czuk A, Maci\u0105\u017cek-Chyra B, Wiland P. Pathophysiology of hyperuricemia and its clinical significance - a narrative review. Reumatologia. 2020, 58:312-23. 10.5114\/reum.2020.100140","journal-title":"Reumatologia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4161\/viru.27135","article-title":"Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?","volume":"5","author":"Balk RA","year":"2014","unstructured":"Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?. Virulence. 2014, 5:20-6. 10.4161\/viru.27135","journal-title":"Virulence"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2019.07.01","article-title":"Spontaneous tumor lysis syndrome in T-cell malignancy: two case reports","volume":"6","author":"Roque W","year":"2019","unstructured":"Roque W, Rehman A, Suero-Abreu GA, et al.. Spontaneous tumor lysis syndrome in T-cell malignancy: two case reports. Stem Cell Investig. 2019, 6:24. 10.21037\/sci.2019.07.01","journal-title":"Stem Cell Investig"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1683025","article-title":"Spontaneous tumor lysis syndrome following liver biopsy: a case report and literature review","volume":"15","author":"Mao W","year":"2025","unstructured":"Mao W, Jiang X, Wang M, Cai K, Hu W, Gong S, Zhao Y. Spontaneous tumor lysis syndrome following liver biopsy: a case report and literature review. Front Oncol. 2025, 15:1683025. 10.3389\/fonc.2025.1683025","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14740\/jh620","article-title":"Spontaneous tumor lysis syndrome: a rare presentation in plasmablastic lymphoma","volume":"10","author":"Infante J","year":"2021","unstructured":"Infante J, Casado A, Almeida A, Messias A. Spontaneous tumor lysis syndrome: a rare presentation in plasmablastic lymphoma. J Hematol. 2021, 10:30-4. 10.14740\/jh620","journal-title":"J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/461870","article-title":"A case of spontaneous tumor lysis syndrome in a patient with ovarian cancer","volume":"2015","author":"Okamoto K","year":"2015","unstructured":"Okamoto K, Kinoshita T, Shimizu M, Okura I, Kawada A, Mizobuchi K, Ando M. A case of spontaneous tumor lysis syndrome in a patient with ovarian cancer. Case Rep Obstet Gynecol. 2015, 2015:461870. 10.1155\/2015\/461870","journal-title":"Case Rep Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2022.33.e25","article-title":"Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma","volume":"33","author":"Hamilton SN","year":"2022","unstructured":"Hamilton SN, Tinker AV, Kwon J, et al.. Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma. J Gynecol Oncol. 2022, 33:e25. 10.3802\/jgo.2022.33.e25","journal-title":"J Gynecol Oncol"},{"key":"ref11","unstructured":"American Cancer Society. Survival rates for uterine sarcoma. (2026). Accessed. August 16, 2026: https:\/\/www.cancer.org\/cancer\/types\/uterine-sarcoma\/detection-diagnosis-staging\/survival-rates.html."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.6026\/97320630010703","article-title":"Development of tumor lysis syndrome (TLS): a potential risk factor in cancer patients receiving anticancer therapy","volume":"10","author":"Rasool M","year":"2014","unstructured":"Rasool M, Malik A, Qureshi MS, et al.. Development of tumor lysis syndrome (TLS): a potential risk factor in cancer patients receiving anticancer therapy. Bioinformation. 2014, 10:703-7. 10.6026\/97320630010703","journal-title":"Bioinformation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2017-0278-RS","article-title":"Tumor lysis syndrome","volume":"143","author":"Williams SM","year":"2019","unstructured":"Williams SM, Killeen AA. Tumor lysis syndrome. Arch Pathol Lab Med. 2019, 143:386-93. 10.5858\/arpa.2017-0278-RS","journal-title":"Arch Pathol Lab Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08143.x","article-title":"Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus","volume":"149","author":"Cairo MS","year":"2010","unstructured":"Cairo MS, Coiffier B, Reiter A, Younes A. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol. 2010, 149:578-86. 10.1111\/j.1365-2141.2010.08143.x","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier B","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008, 26:2767-78. 10.1200\/JCO.2007.15.0177","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13290","article-title":"Consensus conference on the management of tumor lysis syndrome","volume":"93","author":"Tosi P","year":"2008","unstructured":"Tosi P, Barosi G, Lazzaro C, et al.. Consensus conference on the management of tumor lysis syndrome. Haematologica. 2008, 93:1877-85. 10.3324\/haematol.13290","journal-title":"Haematologica"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-022-00990-1","article-title":"Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy","volume":"12","author":"Abdel-Nabey M","year":"2022","unstructured":"Abdel-Nabey M, Chaba A, Serre J, Lenglin\u00e9 E, Azoulay E, Darmon M, Zafrani L. Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy. Ann Intensive Care. 2022, 12:15. 10.1186\/s13613-022-00990-1","journal-title":"Ann Intensive Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2020.1761185","article-title":"Diagnosis and management of tumor lysis syndrome","volume":"10","author":"Puri I","year":"2020","unstructured":"Puri I, Sharma D, Gunturu KS, Ahmed AA. Diagnosis and management of tumor lysis syndrome. J Community Hosp Intern Med Perspect. 2020, 10:269-72. 10.1080\/20009666.2020.1761185","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2016.10.040","article-title":"Tumor lysis syndrome in solid tumors: clinical characteristics and prognosis","volume":"148","author":"Caravaca-Font\u00e1n F","year":"2017","unstructured":"Caravaca-Font\u00e1n F, Mart\u00ednez-S\u00e1ez O, Pampa-Saico S, Olmedo ME, Gomis A, Garrido P. Tumor lysis syndrome in solid tumors: clinical characteristics and prognosis. Med Clin (Barc). 2017, 148:121-4. 10.1016\/j.medcli.2016.10.040","journal-title":"Med Clin (Barc)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-024-04679-1","article-title":"Spontaneous tumor lysis syndrome (STLS) during biopsy for Burkitt lymphoma: a case report","volume":"24","author":"Pan S","year":"2024","unstructured":"Pan S, Shen Q, Zhou J, Li T. Spontaneous tumor lysis syndrome (STLS) during biopsy for Burkitt lymphoma: a case report. BMC Pediatr. 2024, 24:209. 10.1186\/s12887-024-04679-1","journal-title":"BMC Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/528663-spontaneous-tumour-lysis-syndrome-in-metastatic-endometrial-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:32:11Z","timestamp":1791016331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/528663-spontaneous-tumour-lysis-syndrome-in-metastatic-endometrial-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.117379","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,3]]}}}